High-Purity Research Peptides

Showing all 17 results

  • GLP & Metabolic Research

    Retatrutide 5MG

    $45.00 Add to cart

    Retatrutide is a synthetic 39-residue fatty-acid-conjugated peptide acting as a triple agonist at the GIP, GLP-1 and glucagon receptors. The added glucagon receptor activity is what distinguishes it from dual agonists such as tirzepatide, and it appears frequently in comparative metabolic-pharmacology literature.

    This vial contains 5mg of lyophilized powder, equivalent to approximately 1.06 µmol.

    • Vial contents: 5mg lyophilized powder (batch RET-5-260801-L001 tested at 5.86mg)
    • Molar content: approximately 1.06 µmol per vial (based on labeled mass)
    • Molecular weight: 4731.33 g/mol
    • Classification: Triple GIP / GLP-1 / glucagon receptor agonist
    • Sequence: 39-residue modified backbone with fatty-acid conjugate for albumin binding
    • Purity: 99.636% by RP-HPLC (batch RET-5-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • GLP & Metabolic Research

    Retatrutide 20MG

    $68.00 Add to cart

    Retatrutide is a synthetic 39-residue fatty-acid-conjugated peptide acting as a triple agonist at the GIP, GLP-1 and glucagon receptors. The added glucagon receptor activity is what distinguishes it from dual agonists such as tirzepatide, and it appears frequently in comparative metabolic-pharmacology literature.

    This vial contains 20mg of lyophilized powder, equivalent to approximately 4.23 µmol.

    • Vial contents: 20mg lyophilized powder (batch RET-20-260801-L001 tested at 19.80mg)
    • Molar content: approximately 4.23 µmol per vial (based on labeled mass)
    • Molecular weight: 4731.33 g/mol
    • Classification: Triple GIP / GLP-1 / glucagon receptor agonist
    • Sequence: 39-residue modified backbone with fatty-acid conjugate for albumin binding
    • Purity: 99.884% by RP-HPLC (batch RET-20-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • GLP & Metabolic Research

    Retatrutide 30MG

    $111.00 Add to cart

    Retatrutide is a synthetic 39-residue fatty-acid-conjugated peptide acting as a triple agonist at the GIP, GLP-1 and glucagon receptors. The added glucagon receptor activity is what distinguishes it from dual agonists such as tirzepatide, and it appears frequently in comparative metabolic-pharmacology literature.

    This vial contains 30mg of lyophilized powder, equivalent to approximately 6.34 µmol.

    • Vial contents: 30mg lyophilized powder (batch RET-30-260801-L001 tested at 32.83mg)
    • Molar content: approximately 6.34 µmol per vial (based on labeled mass)
    • Molecular weight: 4731.33 g/mol
    • Classification: Triple GIP / GLP-1 / glucagon receptor agonist
    • Sequence: 39-residue modified backbone with fatty-acid conjugate for albumin binding
    • Purity: 99.501% by RP-HPLC (batch RET-30-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • GLP & Metabolic Research

    Tirzepatide 30MG

    $82.00 Add to cart

    Tirzepatide is a synthetic 39-residue peptide carrying a C20 fatty diacid chain that acts as a dual agonist at both the GIP and GLP-1 receptors. It is among the most widely referenced compounds in current incretin and metabolic-signalling literature, and is frequently used as a comparator in receptor-selectivity studies.

    This vial contains 30mg of lyophilized powder, equivalent to approximately 6.23 µmol.

    • Vial contents: 30mg lyophilized powder (batch TIR-30-260801-L001 tested at 30.73mg)
    • Molar content: approximately 6.23 µmol per vial (based on labeled mass)
    • Molecular weight: 4813.45 g/mol
    • Classification: Dual GIP / GLP-1 receptor agonist
    • Sequence: 39-residue modified backbone based on the native GIP sequence, with a C20 diacid linked at Lys20 for albumin binding
    • Purity: 99.576% by RP-HPLC (batch TIR-30-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • GLP & Metabolic Research

    Tirzepatide 60MG

    $110.00 Add to cart

    Tirzepatide is a synthetic 39-residue peptide carrying a C20 fatty diacid chain that acts as a dual agonist at both the GIP and GLP-1 receptors. It is among the most widely referenced compounds in current incretin and metabolic-signalling literature, and is frequently used as a comparator in receptor-selectivity studies.

    This vial contains 60mg of lyophilized powder, equivalent to approximately 12.47 µmol.

    • Vial contents: 60mg lyophilized powder (batch TIR-60-260801-L001 tested at 66.09mg)
    • Molar content: approximately 12.47 µmol per vial (based on labeled mass)
    • Molecular weight: 4813.45 g/mol
    • Classification: Dual GIP / GLP-1 receptor agonist
    • Sequence: 39-residue modified backbone based on the native GIP sequence, with a C20 diacid linked at Lys20 for albumin binding
    • Purity: 99.658% by RP-HPLC (batch TIR-60-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Healing & Recovery Research

    BPC-157 10MG

    $45.00 Add to cart

    BPC-157 is a synthetic 15-amino-acid peptide corresponding to a partial sequence of human gastric juice protein BPC. It is one of the most frequently cited peptides in tissue-repair and gastrointestinal pharmacology research, and its short, unmodified sequence makes it a common reference compound in stability and analytical method development.

    This vial contains 10mg of BPC-157 as a lyophilized powder, equivalent to approximately 7.04 µmol.

    • Vial contents: 10mg lyophilized powder (batch BPC-10-260801-L001 tested at 12.17mg)
    • Molar content: approximately 7.04 µmol per vial (based on labeled mass)
    • Molecular weight: 1419.6 g/mol
    • Classification: Synthetic pentadecapeptide derived from human gastric protein BPC
    • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
    • Purity: 99.724% by RP-HPLC (batch BPC-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Healing & Recovery Research

    KLOW 80MG

    $92.00 Add to cart

    KLOW is a combination formulation rather than a single compound, supplied as one lyophilized vial containing several peptides together. Because it is a blend, it has no single molecular weight or molar equivalent — those figures apply to the individual components rather than to the product as a whole.

    This vial contains 80mg of total peptide mass as a lyophilized powder. The figure refers to the combined content of all components, not to any single one.

    • Vial contents: 80mg lyophilized powder (batch KLW-80-260801-L001 tested at 85.19mg)
    • Components (labeled): GHK-Cu 50mg, KPV 10mg, BPC-157 10mg, TB-500 (TB-4) 10mg — per-component measured values are given on the batch COA
    • Molar content: Not applicable
    • Molecular weight: Not applicable — blend, not a single chemical entity
    • Classification: Multi-peptide combination formulation
    • Sequence: Varies by component
    • Purity: 99.153% blend average by RP-HPLC (batch KLW-80-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Healing & Recovery Research

    GHK-CU 100MG

    $39.00 Add to cart

    GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a naturally occurring sequence first isolated from human plasma. Its copper-chelating behaviour makes it a common subject in tissue-remodelling, dermatological and metal-binding research.

    This vial contains 100mg of GHK-Cu as a lyophilized powder.

    • Vial contents: 100mg lyophilized powder (batch GHK-100-260801-L001 tested at 108.32mg)
    • Molar content: Not stated — depends on which species the batch COA reports
    • Molecular weight: See batch COA — reported values differ between the free peptide and the copper complex
    • Classification: Copper(II)-binding tripeptide complex
    • Sequence: Gly-His-Lys (GHK), copper(II)-chelating
    • Purity: 99.168% by RP-HPLC (batch GHK-100-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Longevity & Mitochondrial Research

    SS-31 10MG

    $45.00 Add to cart

    SS-31, also known as elamipretide or MTP-131, is a four-residue peptide that concentrates in the inner mitochondrial membrane through its affinity for cardiolipin. That targeting behaviour makes it a standard tool compound in mitochondrial bioenergetics and oxidative-stress research.

    This vial contains 10mg of SS-31 as a lyophilized powder, equivalent to approximately 15.63 µmol.

    • Vial contents: 10mg lyophilized powder (batch SST-10-260801-L001 tested at 10.79mg)
    • Molar content: approximately 15.63 µmol per vial (based on labeled mass)
    • Molecular weight: 639.8 g/mol
    • Classification: Mitochondria-targeting, cardiolipin-binding tetrapeptide
    • Sequence: D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2′,6′-dimethyltyrosine
    • Purity: 99.823% by RP-HPLC (batch SST-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Longevity & Mitochondrial Research

    MOTS-C 20MG

    $55.00 Add to cart

    MOTS-c is a 16-residue peptide encoded within the mitochondrial 12S rRNA region rather than the nuclear genome, which makes it one of the more unusual entries in the mitochondrial-derived peptide family. It features regularly in metabolic and exercise-physiology research.

    This vial contains 20mg of MOTS-c as a lyophilized powder, equivalent to approximately 9.20 µmol.

    • Vial contents: 20mg lyophilized powder (batch MTS-20-260801-L001 tested at 22.84mg)
    • Molar content: approximately 9.20 µmol per vial (based on labeled mass)
    • Molecular weight: 2174.6 g/mol
    • Classification: Mitochondrial-derived peptide, mtDNA-encoded
    • Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR)
    • Purity: 99.328% by RP-HPLC (batch MTS-20-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Growth Hormone Research

    Tesamorelin 10MG

    $61.00 Add to cart

    Tesamorelin is a 44-residue analog of growth-hormone-releasing hormone carrying a trans-3-hexenoyl group at the N-terminus, a modification that improves its resistance to enzymatic degradation. It is a common reference compound in GH-axis and lipid-metabolism research.

    This vial contains 10mg of tesamorelin as a lyophilized powder, equivalent to approximately 1.95 µmol.

    • Vial contents: 10mg lyophilized powder (batch TES-10-260801-L001 tested at 11.82mg)
    • Molar content: approximately 1.95 µmol per vial (based on labeled mass)
    • Molecular weight: approximately 5135 g/mol
    • Classification: N-terminally modified GHRH analog
    • Sequence: trans-3-hexenoyl-modified GRF(1-44)-NH2, 44 residues
    • Purity: 99.646% by RP-HPLC (batch TES-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Growth Hormone Research

    Ipamorelin 10MG

    $45.00 Add to cart

    Ipamorelin is a synthetic pentapeptide acting as a selective agonist at the ghrelin receptor (GHSR-1a). That selectivity is why it appears so often in endocrinology research — it allows growth-hormone-axis signalling to be studied in isolation, without the broader hormonal activity seen with less selective secretagogues.

    This vial contains 10mg of ipamorelin as a lyophilized powder, equivalent to approximately 14.05 µmol.

    • Vial contents: 10mg lyophilized powder (batch IPA-10-260801-L001 tested at 10.72mg)
    • Molar content: approximately 14.05 µmol per vial (based on labeled mass)
    • Molecular weight: 711.9 g/mol
    • Classification: Selective growth-hormone secretagogue, ghrelin receptor agonist
    • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 (C-terminal amide)
    • Purity: 99.296% by RP-HPLC (batch IPA-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Growth Hormone Research

    CJC-1295 No Dac 10MG

    $58.00 Add to cart

    CJC-1295 without DAC, also called Modified GRF (1-29), is a 29-residue analog of growth-hormone-releasing hormone carrying four amino acid substitutions that improve its stability relative to native GRF. It lacks the Drug Affinity Complex moiety found in the long-acting version, which makes it a distinct molecule rather than a variant.

    This vial contains 10mg of CJC-1295 without DAC as a lyophilized powder, equivalent to approximately 2.97 µmol.

    • Vial contents: 10mg lyophilized powder (batch CND-10-260801-L001 tested at 10.41mg)
    • Molar content: approximately 2.97 µmol per vial (based on labeled mass)
    • Molecular weight: 3367.9 g/mol
    • Classification: GHRH receptor agonist analog, DAC-free form
    • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
    • Purity: 99.413% by RP-HPLC (batch CND-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Longevity & Mitochondrial Research

    NAD+ 1000MG

    $69.00 Add to cart

    NAD+ is nicotinamide adenine dinucleotide, a redox coenzyme built from adenine and nicotinamide ribonucleotides joined by a pyrophosphate bridge. It is not a peptide. It sits at the centre of cellular energy metabolism and appears throughout mitochondrial and aging research.

    This vial contains 1000mg of NAD+ as a lyophilized powder, equivalent to approximately 1.51 mmol.

    • Vial contents: 1000mg lyophilized powder (batch NAD-1000-260801-L001 tested at 989.42mg)
    • Molar content: approximately 1.51 mmol per vial (based on labeled mass)
    • Molecular weight: 663.4 g/mol
    • Classification: Dinucleotide redox coenzyme (not a peptide)
    • Sequence: Not applicable — NAD+ is a dinucleotide, not a peptide
    • Purity: 99.626% by RP-HPLC (batch NAD-1000-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Peptides

    PT-141 10MG

    $39.00 Add to cart

    PT-141, also known as bremelanotide, is a cyclic seven-residue peptide and an active metabolite of melanotan II. It acts at the melanocortin MC3 and MC4 receptors and is widely used in central nervous system receptor-pharmacology research.

    This vial contains 10mg of PT-141 as a lyophilized powder, equivalent to approximately 9.75 µmol.

    • Vial contents: 10mg lyophilized powder (batch PT-10-260801-L001 tested at 10.81mg)
    • Molar content: approximately 9.75 µmol per vial (based on labeled mass)
    • Molecular weight: 1025.2 g/mol
    • Classification: Cyclic melanocortin MC3R / MC4R receptor agonist
    • Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
    • Purity: 99.276% by RP-HPLC (batch PT-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Cognitive & Neuro Research

    Semax 10MG

    $39.00 Add to cart

    Semax is a synthetic seven-residue peptide based on the ACTH(4-10) fragment, with a Pro-Gly-Pro extension that increases its stability. It is a long-standing reference compound in neuroprotection and cognition research.

    This vial contains 10mg of semax as a lyophilized powder, equivalent to approximately 12.29 µmol.

    • Vial contents: 10mg lyophilized powder (batch SMX-10-260801-L001 tested at 10.54mg)
    • Molar content: approximately 12.29 µmol per vial (based on labeled mass)
    • Molecular weight: 813.9 g/mol
    • Classification: Synthetic ACTH(4-10) analog heptapeptide
    • Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
    • Purity: 99.603% by RP-HPLC (batch SMX-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

  • Cognitive & Neuro Research

    Selank 10MG

    $39.00 Add to cart

    Selank is a synthetic seven-residue peptide derived from the immunomodulatory peptide tuftsin, extended with a Pro-Gly-Pro tail that slows enzymatic breakdown. It appears regularly in neuropsychopharmacology research literature.

    This vial contains 10mg of selank as a lyophilized powder, equivalent to approximately 13.30 µmol.

    • Vial contents: 10mg lyophilized powder (batch SLN-10-260801-L001 tested at 11.84mg)
    • Molar content: approximately 13.30 µmol per vial (based on labeled mass)
    • Molecular weight: 751.9 g/mol
    • Classification: Synthetic heptapeptide analog of tuftsin
    • Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
    • Purity: 99.861% by RP-HPLC (batch SLN-10-260801-L001) — see COA

    For laboratory research use only. Not for human or veterinary use.

Shopping Cart

Filter by price

JOIN THE ORION COMMUNITY

Unlock 15% Off Your First Order

Research-grade peptides, third-party tested at 99%+ purity. Get early access to new product drops, research updates and member-only offers.

Third-party tested at 99%+ purity.